- Home
- MESO vs EPC Comparison
MESO vs EPC Comparison
Compare MESO & EPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESO
- EPC
- Stock Information
- Founded
- MESO 2004
- EPC 1999
- Country
- MESO Australia
- EPC United States
- Employees
- MESO N/A
- EPC N/A
- Industry
- MESO Biotechnology: Biological Products (No Diagnostic Substances)
- EPC Package Goods/Cosmetics
- Sector
- MESO Health Care
- EPC Consumer Discretionary
- Exchange
- MESO Nasdaq
- EPC Nasdaq
- Market Cap
- MESO 1.4B
- EPC 1.4B
- IPO Year
- MESO N/A
- EPC 2000
- Fundamental
- Price
- MESO $10.97
- EPC $27.07
- Analyst Decision
- MESO Buy
- EPC Buy
- Analyst Count
- MESO 4
- EPC 7
- Target Price
- MESO $18.00
- EPC $33.00
- AVG Volume (30 Days)
- MESO 156.4K
- EPC 514.7K
- Earning Date
- MESO 02-26-2025
- EPC 05-07-2025
- Dividend Yield
- MESO N/A
- EPC 2.21%
- EPS Growth
- MESO N/A
- EPC N/A
- EPS
- MESO N/A
- EPC 1.72
- Revenue
- MESO $5,670,000.00
- EPC $2,224,500,000.00
- Revenue This Year
- MESO $152.37
- EPC $0.77
- Revenue Next Year
- MESO $336.12
- EPC $2.25
- P/E Ratio
- MESO N/A
- EPC $15.87
- Revenue Growth
- MESO N/A
- EPC N/A
- 52 Week Low
- MESO $5.78
- EPC $24.35
- 52 Week High
- MESO $22.00
- EPC $41.50
- Technical
- Relative Strength Index (RSI)
- MESO 44.34
- EPC 31.11
- Support Level
- MESO $10.77
- EPC $24.35
- Resistance Level
- MESO $11.61
- EPC $30.85
- Average True Range (ATR)
- MESO 0.47
- EPC 0.93
- MACD
- MESO 0.09
- EPC -0.37
- Stochastic Oscillator
- MESO 27.68
- EPC 40.66
About MESO Mesoblast Limited
Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.
About EPC Edgewell Personal Care Company
Edgewell Personal Care Co is a personal-care company. The operating segments of the company include Wet Shave, Sun and Skin Care and Feminine Care. Some of the brands offered by the company include Edge, Skintimate, Personna, Schick, Carefree, Playtex, Banana Boat and Hawaiian Tropic. It derives a majority of its revenue from the United States.